Universal Access of TB Services to PLHIV: Harnessing Collaboration and Coordination  SUSAT47

Organiser:
Type:
Non-Commercial Satellite Back
Venue: SR 10 (950)
Interpretation: None
Time: 15:45 - 17:45, 03.08.2008
Code: SUSAT47


Click here to see a webcast of this session on kaisernetwork.org

CO-ORGANISERS
The World Health Organization, International AIDS Society, the Global Fund for AIDS, TB and Malaria, UNAIDS and the Forum for Collaborative HIV Research on behalf of the Global TB/HIV Working Group of the Stop TB Partnership.

RATIONALE
TB is a curable and preventable disease that still kills 4000 people every day. There are nearly 700,000 HIV positive TB patients globally and most have not yet received HIV treatment and care. TB is the leading cause of death among people living with HIV (PLHIV) in Africa and a major cause of death elsewhere. It is also the most common presenting illness among PLHIV on ARV treatment worldwide. The increasing emergence of extensively drug resistant (XDR) TB and the associated high mortality rate among PLHIV calls for urgent actions to be taken by all stakeholders, particularly HIV policy makers and service providers.

OBJECTIVE
The satellite session will address the key strategic and practical issues to reduce the burden of TB in PLHIV in order to ensure the universal access of TB prevention, diagnosis and treatment services. Particular emphasis will be given to the opportunities and challenges of mainstreaming the critical interventions branded as Three 'Is' for HIV TB- Intensified TB case finding, Isoniazid preventive therapy and Infection control for TB-in HIV care and treatment services. Successful implementation country experience will be presented, what works and what doesn't will be discussed and next steps will be laid out. Recent advances in the monitoring and evaluation of collaborative TB/HIV activities and harmonizing the core indicators among different global stakeholders will also be shared.

AUDIENCE:
All HIV service providers, HIV program implementers, PLHIV activists and advocates, HIV researchers, representatives of NGOs and Faith Based Organizations (FBOs), and global and national HIV policy-makers and program managers.

FOLLOW UP OF OUTCOMES:
The key outcomes of the satellite symposium will be published in the daily newsletter of the Conference (Panoscope) the next day and will be distributed to 15,000 delegates of the conference. It will also be posted on various websites. A meeting report will be prepared and will be shared widely with HIV and TB stakeholders.


The World Health Organization, International AIDS Society, the Global Fund for AIDS, TB and Malaria, UNAIDS and the Forum for Collaborative HIV Research on behalf of the Global TB/HIV Working Group of the Stop TB Partnership.



Presentations in this session:

15:45
SUSAT4701
Three 'Is' for HIV TB- Intensified TB case finding, Isoniazid preventive therapy and Infection control for TB- for people living with HIV: why now?
Kevin De Cock, Switzerland


15:55
SUSAT4702
TB prevention, diagnosis and treatment services for PLHIV: scale-up implications for HIV implementers.
Mark Dybul, United States


16:05
SUSAT4703
Powerpoint (521 KB)
HIV/TB for PLHIV: Implications for Activism and Advocacy
Musa Njoko


16:15
SUSAT4704
Discussion


16:35
SUSAT4705
Powerpoint (706 KB)
Country experience in implementation of collaborative HIV/TB activities.
Anupong Chitwarakorn


16:45
SUSAT4706
Country experience in implementation of collaborative HIV/TB activities.
Henry Akpan, Nigeria


16:55
SUSAT4707
Powerpoint (1.52 MB)
Commentary on country implementation: what are the triggers?
Paul Nunn, Switzerland


17:05
SUSAT4708
Overall Discussion








   

   

    The organizers reserve the right to amend the programme.


Copyright Notice © IAS Disclaimer